Dr. V. Bobby Bringi serves as Research Professor at msu’s Department of Chemical Engineering & Materials Science. Dr. Bringi leads the team of developers working to commercialize afex—a disruptive technology that upgrades underutilized agricultural residues into high-quality cattle feed as well as a feedstock for biobased fuels and chemicals. The afex project is a collaborative partnership between msu, mbi, and other international institutions and agencies. Dr. Bringi was the co-founder of Phyton, a venture that developed and commercialized a groundbreaking route to the sustainable production of the anti-cancer drug, Taxol, in collaboration with Bristol Myers Squibb. He later served as ceo of mbi, presiding over its growth into a well-respected biotechnology hub that has been sought after by leading industry and academic innovators for derisking and scale-up services. He earned his doctorate from Cornell University in chemical engineering. In 2015, Bringi was elected as a Fellow of the American Institute for Medical and Biological Engineering.
Ph.D, Chemical Engineering, Cornell University
MSU Scholars ID